Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis of glomerular damage in glomerulonephritis

W G Couser1

  • 1Department of Medicine, University of Washington, Seattle 98195, USA.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|March 21, 1998
PubMed
Summary

Recent advances illuminate the cellular and molecular mechanisms of glomerular diseases, paving the way for novel therapies targeting complement, inflammatory cells, and growth factors to improve kidney health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

World kidney day 2011: protect your kidneys, save your heart.

International journal of organ transplantation medicine·2014
Same author

World Kidney Day 2011: protect your kidneys, save your heart.

Internal medicine journal·2012
Same author

Meeting report on the Bellagio Conference 'prevention of vascular diseases in the emerging world: An approach to global health equity'.

Kidney international·2006
Same author

Endothelial chylomicron binding is altered by interaction with high-density lipoprotein in Heymann's nephritis.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
Same author

Intravenous immunoglobulin protects against experimental thrombotic microangiopathy.

Kidney international·2001
Same author

Complement (C5b-9) induces DNA synthesis in rat mesangial cells in vitro.

Kidney international·2001

Area of Science:

  • Nephrology
  • Immunology
  • Molecular Biology

Background:

  • Glomerular disease is a leading cause of end-stage renal disease globally.
  • Recent research has significantly advanced the understanding of the cellular and molecular underpinnings of these conditions.
  • Key non-inflammatory lesions like minimal change disease and membranous nephropathy involve glomerular endothelial cells (GEC).

Purpose of the Study:

  • To elucidate the mechanisms of glomerular injury in various kidney diseases.
  • To explore the role of cellular and molecular pathways in disease pathogenesis.
  • To identify potential therapeutic targets for glomerular disorders.

Main Methods:

  • Investigating the effects of antibodies on glomerular endothelial cells (GEC) in animal models.

Related Experiment Videos

  • Analyzing the role of complement component C5b-9 in proteinuria and mesangial proliferative glomerulonephritis.
  • Examining the contribution of inflammatory cells, including neutrophils and activated mesangial cells, to tissue injury.
  • Studying cell-mediated immune responses in glomerulonephritis.

    • Main Results:

    • Antibodies targeting GEC can induce loss of glomerular barrier function, contributing to minimal change disease and focal sclerosis.
    • Complement component C5b-9 plays a crucial role in proteinuria in membranous nephropathy and other glomerular lesions.
    • Inflammatory cells and activated mesangial cells contribute to glomerular injury through proteases, oxidants, and growth factors like TGF-beta.
    • Cell-mediated immunity, independent of humoral immunity, can drive glomerulonephritis.

    Conclusions:

    • Understanding the intricate cellular and molecular mechanisms of glomerular diseases opens avenues for targeted therapies.
    • Therapeutic strategies may involve inhibiting complement, leukocyte adhesion molecules, oxidants, proteases, and cytokines.
    • Upregulating natural complement regulatory proteins presents a promising therapeutic approach.
    • These insights are expected to lead to more specific and effective treatments for kidney diseases in the near future.